Biotechnology Stocks News Analysis: XOMA (NASDAQ:XOMA), Retrophin (NASDAQ:RTRX), Orexigen Therapeutics, (NASDAQ:OREX)
On Wednesday, XOMA Corp (NASDAQ:XOMA)’s shares declined -6.49% to $1.73. XOMA offered -55.90% EPS for prior five years. The company has 450.30% return on equity value while its ROI ratio was -213.00%. The company has $219.38 million market capitalizations and...